Cholangiocarcinoma risk factors: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) No edit summary |
|||
| (18 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Cholangiocarcinoma}} | ||
{{CMG}}; {{AE}} {{F.K}} {{PSK}} | {{CMG}}; {{AE}} {{F.K}}, {{PSK}} | ||
==Overview== | ==Overview== | ||
Common [[risk factors]] in the development of cholangiocarcinoma include [[primary sclerosing cholangitis]], fibropolycystic liver disease such as [[choledochal cysts]], [[hepatolithiasis]] and recurrent pyogenic [[cholangitis]]. | |||
==Risk Factors== | ==Risk Factors== | ||
* | *Common risk factors in the development of cholangiocarcinoma include primary sclerosing cholangitis, fibropolycystic liver disease such as [[choledochal cysts]], [[hepatolithiasis]] and recurrent pyogenic [[cholangitis]]. | ||
===Common Risk Factors=== | ===Common Risk Factors=== | ||
*Common risk factors in the development of | *Common risk factors in the development of cholangiocarcinoma include:<ref name="pmid23694797">{{cite journal |vauthors=Al-Bahrani R, Abuetabh Y, Zeitouni N, Sergi C |title=Cholangiocarcinoma: risk factors, environmental influences and oncogenesis |journal=Ann. Clin. Lab. Sci. |volume=43 |issue=2 |pages=195–210 |year=2013 |pmid=23694797 |doi= |url=}}</ref><ref name="pmid21488076">{{cite journal |vauthors=Tyson GL, El-Serag HB |title=Risk factors for cholangiocarcinoma |journal=Hepatology |volume=54 |issue=1 |pages=173–84 |year=2011 |pmid=21488076 |pmc=3125451 |doi=10.1002/hep.24351 |url=}}</ref><ref name="pmid17625428">{{cite journal |vauthors=Ben-Menachem T |title=Risk factors for cholangiocarcinoma |journal=Eur J Gastroenterol Hepatol |volume=19 |issue=8 |pages=615–7 |year=2007 |pmid=17625428 |doi=10.1097/MEG.0b013e328224b935 |url=}}</ref><ref name="pmid20496549">{{cite journal |vauthors=Gatto M, Alvaro D |title=Cholangiocarcinoma: risk factors and clinical presentation |journal=Eur Rev Med Pharmacol Sci |volume=14 |issue=4 |pages=363–7 |year=2010 |pmid=20496549 |doi= |url=}}</ref><ref name="pmid15529594">{{cite journal |vauthors=Acalovschi M |title=Cholangiocarcinoma: risk factors, diagnosis and management |journal=Rom J Intern Med |volume=42 |issue=1 |pages=41–58 |year=2004 |pmid=15529594 |doi= |url=}}</ref> | ||
* | **[[Primary sclerosing cholangitis]] | ||
**[ | **[[Cirrhosis]] | ||
**[ | **Viral infections | ||
**[ | ***[[HIV]] | ||
***[[EBV]] | |||
***[[Hepatitis]] viruses | |||
****[[Hepatitis B]] | |||
****[[Hepatitis C]] | |||
**[[Liver fluke]] infections | |||
**[[Hepatolithiasis]] | |||
**[[Choledochal cysts]] | |||
**Infusion of certain chemical agents such as naphthenic acids | |||
**Recurrent pyogenic [[cholangitis]] | |||
**[[Opisthorchis viverrini]] | |||
**[[Clonorchis sinensis]] | |||
**Caroli's disease | |||
**Inherited disorders | |||
***[[Lynch syndrome]] | |||
***Biliary papillomatosis | |||
===Less Common Risk Factors=== | ===Less Common Risk Factors=== | ||
*Less common risk factors in the development of [ | *Less common risk factors in the development of cholangiocarcinoma include:<ref name="pmid22982100">{{cite journal |vauthors=Razumilava N, Gores GJ |title=Classification, diagnosis, and management of cholangiocarcinoma |journal=Clin. Gastroenterol. Hepatol. |volume=11 |issue=1 |pages=13–21.e1; quiz e3–4 |year=2013 |pmid=22982100 |pmc=3596004 |doi=10.1016/j.cgh.2012.09.009 |url=}}</ref> | ||
**[ | **[[Thorotrast]] | ||
**[ | **[[Diabetes]] | ||
**[ | **[[Obesity]] | ||
**[[Alcohol]] consumption | |||
**[[Smoking]] | |||
==References== | ==References== | ||
Latest revision as of 15:18, 12 February 2018
|
Cholangiocarcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholangiocarcinoma risk factors On the Web |
|
American Roentgen Ray Society Images of Cholangiocarcinoma risk factors |
|
Risk calculators and risk factors for Cholangiocarcinoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2], Suveenkrishna Pothuru, M.B,B.S. [3]
Overview
Common risk factors in the development of cholangiocarcinoma include primary sclerosing cholangitis, fibropolycystic liver disease such as choledochal cysts, hepatolithiasis and recurrent pyogenic cholangitis.
Risk Factors
- Common risk factors in the development of cholangiocarcinoma include primary sclerosing cholangitis, fibropolycystic liver disease such as choledochal cysts, hepatolithiasis and recurrent pyogenic cholangitis.
Common Risk Factors
- Common risk factors in the development of cholangiocarcinoma include:[1][2][3][4][5]
- Primary sclerosing cholangitis
- Cirrhosis
- Viral infections
- Liver fluke infections
- Hepatolithiasis
- Choledochal cysts
- Infusion of certain chemical agents such as naphthenic acids
- Recurrent pyogenic cholangitis
- Opisthorchis viverrini
- Clonorchis sinensis
- Caroli's disease
- Inherited disorders
- Lynch syndrome
- Biliary papillomatosis
Less Common Risk Factors
- Less common risk factors in the development of cholangiocarcinoma include:[6]
- Thorotrast
- Diabetes
- Obesity
- Alcohol consumption
- Smoking
References
- ↑ Al-Bahrani R, Abuetabh Y, Zeitouni N, Sergi C (2013). "Cholangiocarcinoma: risk factors, environmental influences and oncogenesis". Ann. Clin. Lab. Sci. 43 (2): 195–210. PMID 23694797.
- ↑ Tyson GL, El-Serag HB (2011). "Risk factors for cholangiocarcinoma". Hepatology. 54 (1): 173–84. doi:10.1002/hep.24351. PMC 3125451. PMID 21488076.
- ↑ Ben-Menachem T (2007). "Risk factors for cholangiocarcinoma". Eur J Gastroenterol Hepatol. 19 (8): 615–7. doi:10.1097/MEG.0b013e328224b935. PMID 17625428.
- ↑ Gatto M, Alvaro D (2010). "Cholangiocarcinoma: risk factors and clinical presentation". Eur Rev Med Pharmacol Sci. 14 (4): 363–7. PMID 20496549.
- ↑ Acalovschi M (2004). "Cholangiocarcinoma: risk factors, diagnosis and management". Rom J Intern Med. 42 (1): 41–58. PMID 15529594.
- ↑ Razumilava N, Gores GJ (2013). "Classification, diagnosis, and management of cholangiocarcinoma". Clin. Gastroenterol. Hepatol. 11 (1): 13–21.e1, quiz e3–4. doi:10.1016/j.cgh.2012.09.009. PMC 3596004. PMID 22982100.